Cellcolabs Clinical Spv Limited

This early-stage trial tested whether a single infusion of StromaForte, made from donor bone marrow cells, is safe for people with aging frailty. Twelve adults aged 60 to 85 who were mildly or moderately frail received the treatment. Researchers tracked side effects and changes i…

This early-stage study tested a single injection of StromaForte, a stem cell product, in 12 people with mild-to-moderate knee osteoarthritis. The main goal was to check safety and tolerability over 24 weeks. Researchers also looked at whether the treatment reduced knee pain. The …